The overall mean value for the plasma insulin/glucose ratio in the 100 MetS patients averaged 4.31 ± 0.07 μU/mol and, as such, was significantly lower in these patients than in the obese control subjects. The gene discussed is INS; the disease is metabolic syndrome.